艾伯维大跌!

药时代
12 Nov 2024

周一(2024年11月11日)收盘,艾伯维股价暴跌超过12%,市值损失超过300亿美元。这样的情况对近两年股价一路高涨的艾伯维来讲并不常见,甚至放在所有MNC中,这也是过去一段时间中最大的单日股价跌幅之一。至于下跌的原因,则与艾伯维宣布失败的两项临床试验有关。就在周一,艾伯维宣布其在研精神分裂症药物Emraclidine的两项II期临床试验均未达到主要终点。Emraclidine是艾伯维收购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10